DR. GEORGE CYRIAC M.D. NPI 1477843100

NPI Details

DR. George Cyriac, M.D. is a hematology and oncology internal medicine in Port Jefferson Station, NY with 15 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. George Cyriac, M.D. NPI is 1477843100. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:2011

The provider's business location address is:

49 NESCONSET HWY
PORT JEFFERSON STATION, NY
ZIP 11776-628
Phone: (631) 751-3000
Fax: (631) 509-6559

The NPI 1477843100 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram (HCPCS:J1442)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Phosphate level (HCPCS:84100)
• Magnesium level (HCPCS:83735)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Uric acid level, blood (HCPCS:84550)
• Injection, rituximab-arrx, biosimilar, (riabni), 10 mg (HCPCS:Q5123)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, atropine sulfate, 0.01 mg (HCPCS:J0461)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Iron binding capacity (HCPCS:83550)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Red blood count, manual test (HCPCS:85044)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Protein measurement, serum (HCPCS:84165)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Folic acid level, serum (HCPCS:82746)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Vitamin d-3 level (HCPCS:82306)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Blood test, clotting time (HCPCS:85610)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection of drug or substance into vein (HCPCS:96374)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Urinalysis, manual test (HCPCS:81002)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Haptoglobin (serum protein) level (HCPCS:83010)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Hemoglobin a1c level (HCPCS:83036)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Drawing of blood for a medical problem (HCPCS:99195)
• Acute hepatitis panel (HCPCS:80074)
• Testosterone (hormone) level, total (HCPCS:84403)
• Thyroxine (thyroid chemical), total (HCPCS:84436)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Bilirubin level, total (HCPCS:82247)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Albumin (protein) level (HCPCS:82040)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Lactic acid level (HCPCS:83605)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Blood creatinine level (HCPCS:82565)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Injection, lorazepam, 2 mg (HCPCS:J2060)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Molecular pathology procedure; physician interpretation and report (HCPCS:G0452)
• Gene analysis (calreticulin), common variants (HCPCS:81219)
• Gene analysis (janus kinase 2) variant (HCPCS:81270)
• Gene analysis (mpl proto-oncogene, thrombopoietin receptor) for detection of common variants (HCPCS:81338)
• Gene analysis (janus kinase 2) targeted sequence analysis (HCPCS:81279)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• Phosphatase (enzyme) measurement, acid, total (HCPCS:84060)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Measurement c-reactive protein for detection of infection or inflammation, high sensitivity (HCPCS:86141)
• Rheumatoid factor level (HCPCS:86431)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Ige (immune system protein) level (HCPCS:82785)
• Stool analysis for blood to screen for colon tumors (HCPCS:82270)
• Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)
• Liver function blood test panel (HCPCS:80076)
• Bilirubin level, direct (HCPCS:82248)
• Blood glucose (sugar) level (HCPCS:82947)
• Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99439)
• Detection test by immunoassay technique for hiv-1 antigen and hiv-1 and hiv-2 antibodies (HCPCS:87389)
• Detection test by nucleic acid for multiple types influenza virus (HCPCS:87502)
• Blood smear for iron (HCPCS:85536)

The enumeration date for this NPI number is 4/14/2011 and was last updated on 1/17/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: